Revenue (QQ4 2024): 211,185,500; YoY change: -51.99%; QoQ change: 0.00%. Gross Profit: 145,847,000; Gross Margin: 69.06%; YoY Gross Profit change: -39.52%; QoQ change: 0.00%. EBITDA: 36,883,000; EBITDA Margin: 17.46%; Operating Income: 29,752,000; Operating Margin: 14.09%; Net Income: 21,584,000; Net Margin: 10.22%; EPS: 1.07; YoY EPS change: -52.86%; QoQ change: 0.00%. R&D: 225,000; SG&A: 115,870,000; Selling & Marketing: 92,645,500; Administrative: 23,224,500. Depreciation & Amortization: 7,131,000. Net cash from operating activities: 66,421,499; Investing cash flow: -7,003,500 (capex was -8,392,500); Free Cash Flow: 58,029,000. Dividends paid: -22,657,500. Net financing cash flow: -46,254,500. Cash at end of period: 407,087,000. Balance sheet highlights: Total assets 1,657,599,000; Total liabilities 956,011,000; Total equity 701,588,000; Cash and equivalents 407,087,000; Short-term debt 185,145,000; Long-term debt 580,680,000; Net debt 358,738,000. Current assets 576,911,000; Current liabilities 374,430,000; Inventory 98,279,000; Accounts receivable 16,315,000; Accounts payable 51,092,000. Leverage indicators: Debt/Equity β 1.09x; Debt/Assets β 0.46x; Current ratio β 1.54x.